文献速递细菌感染、耐药与抗菌药物医院感染防控

13价肺炎球菌结合疫苗对柬埔寨儿童定植与侵袭性疾病的影响

Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children.
PubMed 文献 · Clin Infect Dis · 2020-01-01

柬埔寨于2015年1月引入PCV13(3+0方案,无补种),本研究通过6次定植调查和医院IPD数据评估疫苗效果。2016-2018年相比2014年,全肺炎球菌定植VE为16.6%,疫苗血清型定植VE为39.2%,多重耐药定植下降26.0%;至2018年IPD发病率下降26.4%,疫苗血清型IPD下降36.3%,非疫苗血清型IPD上升101.4%。

要点

  • PCV13引入后疫苗血清型定植和IPD显著下降
  • 非疫苗血清型IPD上升101.4%,需持续监测
  • 多重耐药肺炎球菌定植下降26.0%

核心结论

  • PCV13纳入柬埔寨免疫规划后,<5岁儿童疫苗血清型肺炎球菌定植和侵袭性疾病下降,但非疫苗血清型IPD增加。

研究设计与样本

  • 2014年1月至2018年1月在暹粒某非政府儿科医院门诊开展6次定植调查,采集鼻咽拭子进行表型和基因型检测。
  • 从医院数据库获取2012年1月至2018年12月IPD数据,对疫苗前IPD数据和疫苗前后定植数据建模估计疫苗效果。

主要发现

  • 相比2014年,2016-2018年全肺炎球菌定植VE为16.6%(95%CI 10.6-21.8),疫苗血清型定植VE为39.2%(95%CI 26.7-46.1)。
  • 多重耐药肺炎球菌定植下降26.0%(95%CI 17.7-33.0)。
  • 至2018年IPD发病率估计下降26.4%(95%CI 14.4-35.8),疫苗血清型IPD下降36.3%(95%CI 23.8-46.9),非疫苗血清型IPD上升101.4%(95%CI 62.0-145.4)。

临床怎么用

  • 支持在类似人群中引入PCV13以降低疫苗血清型肺炎球菌定植和侵袭性疾病。
  • 需持续监测非疫苗血清型IPD和抗菌药物耐药性的变化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Cambodia introduced the 13-valent pneumococcal conjugate vaccine (PCV13) in January 2015 using a 3 + 0 dosing schedule and no catch-up campaign. We investigated the effects of this introduction on pneumococcal colonization and invasive disease in children aged <5 years. METHODS: There were 6 colonization surveys done between January 2014 and January 2018 in children attending the outpatient department of a nongovernmental pediatric hospital in Siem Reap. Nasopharyngeal swabs were analyzed by phenotypic and genotypic methods to detect pneumococcal serotypes and antimicrobial resistance. Invasive pneumococcal disease (IPD) data for January 2012-December 2018 were retrieved from hospital databases. Pre-PCV IPD data and pre-/post-PCV colonization data were modelled to estimate vaccine effectiveness (VE). RESULTS: Comparing 2014 with 2016-2018, and using adjusted prevalence ratios, VE estimates for colonization were 16.6% (95% confidence interval [CI] 10.6-21.8) for all pneumococci and 39.2% (95% CI 26.7-46.1) for vaccine serotype (VT) pneumococci. There was a 26.0% (95% CI 17.7-33.0) decrease in multidrug-resistant pneumococcal colonization. The IPD incidence was estimated to have declined by 26.4% (95% CI 14.4-35.8) by 2018, with a decrease of 36.3% (95% CI 23.8-46.9) for VT IPD and an increase of 101.4% (95% CI 62.0-145.4) for non-VT IPD. CONCLUSIONS: Following PCV13 introduction into the Cambodian immunization schedule, there have been declines in VT pneumococcal colonization and disease in children aged <5 years. Modelling of dominant serotype colonization data produced plausible VE estimates.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Turner P, Leab P, Ly S, et al. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Colonization and Invasive Disease in Cambodian Children. Clin Infect Dis. 2020. PMID: 31175819. doi:10.1093/cid/ciz481

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。